Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |